2 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 28464908 | A phase-I study of lapatinib in combination with foretinib, a c-MET, AXL and vascular endothelial growth factor receptor inhibitor, in human epidermal growth factor receptor 2 (HER-2)-positive metastatic breast cancer. | 2017 May 2 | 1 |
| 2 | 19808973 | Inhibition of tumor cell growth, invasion, and metastasis by EXEL-2880 (XL880, GSK1363089), a novel inhibitor of HGF and VEGF receptor tyrosine kinases. | 2009 Oct 15 | 1 |